Professor Tore Bengtsson is awarded a SEK 2 million grant from Diabetes Wellness Sverige
Tore Bengtsson and his group at the Department of Molecular Biosciences, The Wenner-Gren Institute, have been awarded a SEK 2 million grant from Diabetes Wellness Sverige for their research on a new treatment of type 2 diabetes.
The grant is awarded the project "Novel selectively targeted stimulation of the β2-adrenoceptor for the treatment of type 2 diabetes", in which Tore Bengtsson and his group introduce a new way for the body to control its blood sugar levels.
The novel method helps the body to lower its blood sugar levels by stimulating a cellular receptor called the β2-adrenoceptor (β2-AR) in a new way. This has the potential to lead to the development of new drugs, and to revolutionize how doctors treat diabetes.
Last updated: May 23, 2023
Source: MBW